PBYI
Puma Biotechnology Inc
NASDAQ: PBYI · HEALTHCARE · BIOTECHNOLOGY
$7.48
-0.80% today
Updated 2026-04-29
Market cap
$382.08M
P/E ratio
12.31
P/S ratio
1.67x
EPS (TTM)
$0.61
Dividend yield
—
52W range
$3 – $8
Volume
0.4M
Puma Biotechnology Inc (PBYI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
13.60%
Operating margin
22.70%
ROE
28.00%
ROA
10.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | — | $-15.09M | — | — | — |
| 2008 | — | $-14083.00 | — | — | — |
| 2009 | — | $-16836.00 | — | — | — |
| 2010 | — | $-15976.00 | — | — | — |
| 2011 | $-281096.00 | $-10.23M | 100.00% | 3,613.24% | 3,640.35% |
| 2012 | $0.00 | $-74.30M | — | — | — |
| 2013 | $0.00 | $-54.66M | — | — | — |
| 2014 | $0.00 | $-142.00M | — | — | — |
| 2015 | $0.00 | $-239.30M | — | — | — |
| 2016 | $0.00 | $-276.00M | — | — | — |
| 2017 | $27.70M | $-292.00M | 79.78% | -1,055.60% | -1,054.15% |
| 2018 | $251.00M | $-113.60M | 86.22% | -37.73% | -45.26% |
| 2019 | $272.26M | $-75.59M | 86.48% | -27.77% | -27.77% |
| 2020 | $225.11M | $-59.99M | 82.51% | -13.51% | -26.65% |
| 2021 | $253.16M | $-29.13M | 74.84% | 0.51% | -11.51% |
| 2022 | $228.03M | $2000.00 | 75.84% | 10.40% | 0.00% |
| 2023 | $235.64M | $21.59M | 73.40% | 13.85% | 9.16% |
| 2024 | $230.47M | $30.28M | 72.06% | 13.44% | 13.14% |
| 2025 | $228.37M | $31.11M | 74.53% | 16.33% | 13.62% |